Published in Ned Tijdschr Geneeskd on May 16, 2009
Seroprevalence of pertussis in The Netherlands: evidence for increased circulation of Bordetella pertussis. PLoS One (2010) 1.61
Carriage of Streptococcus pneumoniae 3 years after start of vaccination program, the Netherlands. Emerg Infect Dis (2011) 1.49
Long-term effects of pneumococcal conjugate vaccine on nasopharyngeal carriage of S. pneumoniae, S. aureus, H. influenzae and M. catarrhalis. PLoS One (2012) 1.43
How orthodox protestant parents decide on the vaccination of their children: a qualitative study. BMC Public Health (2012) 1.10
Epidemic of mumps among vaccinated persons, The Netherlands, 2009-2012. Emerg Infect Dis (2014) 1.02
Development of a bead-based multiplex immunoassay for simultaneous quantitative detection of IgG serum antibodies against measles, mumps, rubella, and varicella-zoster virus. Clin Vaccine Immunol (2012) 0.93
Determinants of HPV vaccination intentions among Dutch girls and their mothers: a cross-sectional study. BMC Public Health (2013) 0.93
Is a single dose of meningococcal serogroup C conjugate vaccine sufficient for protection? experience from the Netherlands. BMC Infect Dis (2012) 0.90
An exploratory qualitative assessment of factors influencing childhood vaccine providers' intention to recommend immunization in the Netherlands. BMC Public Health (2012) 0.84
Participation in and attitude towards the national immunization program in the Netherlands: data from population-based questionnaires. BMC Public Health (2012) 0.84
Disease Burden of 32 Infectious Diseases in the Netherlands, 2007-2011. PLoS One (2016) 0.83
Population-based childhood overweight prevention: outcomes of the 'Be active, eat right' study. PLoS One (2013) 0.82
How healthcare professionals respond to parents with religious objections to vaccination: a qualitative study. BMC Health Serv Res (2012) 0.81
The role of religious leaders in promoting acceptance of vaccination within a minority group: a qualitative study. BMC Public Health (2013) 0.78
Negative attitude and low intention to vaccinate universally against varicella among public health professionals and parents in the Netherlands: two internet surveys. BMC Infect Dis (2016) 0.75
A few years later. Update of the cost-effectiveness of infant pneumococcal vaccination in Dutch children. Hum Vaccin Immunother (2014) 0.75
Dutch national immunization schedule: compliance and associated characteristics for the primary series. Eur J Pediatr (2017) 0.75
Effects of pneumococcal conjugate vaccine 2 years after its introduction, the Netherlands. Emerg Infect Dis (2010) 2.48
Waning of maternal antibodies against measles, mumps, rubella, and varicella in communities with contrasting vaccination coverage. J Infect Dis (2013) 1.91
Impact of acellular pertussis preschool booster vaccination on disease burden of pertussis in The Netherlands. Pediatr Infect Dis J (2008) 1.69
Seroprevalence of pertussis in The Netherlands: evidence for increased circulation of Bordetella pertussis. PLoS One (2010) 1.61
Invasive pneumococcal disease and 7-valent pneumococcal conjugate vaccine, the Netherlands. Emerg Infect Dis (2012) 1.50
Pertussis in the Netherlands, is the current vaccination strategy sufficient to reduce disease burden in young infants? Vaccine (2013) 1.24
Pathogen adaptation under imperfect vaccination: implications for pertussis. Proc Biol Sci (2005) 1.24
Immunity against Neisseria meningitidis serogroup C in the Dutch population before and after introduction of the meningococcal c conjugate vaccine. PLoS One (2010) 1.15
Protection from routine vaccination at the age of 14 months with meningococcal serogroup C conjugate vaccine in the Netherlands. Pediatr Infect Dis J (2006) 1.14
Mumps outbreak in a highly vaccinated student population, The Netherlands, 2004. Vaccine (2010) 1.10
Seroprevalence of seven high-risk HPV types in The Netherlands. Vaccine (2012) 1.09
Is it cost-effective to introduce rotavirus vaccination in the Dutch national immunization program? Vaccine (2010) 1.01
Why parents refuse childhood vaccination: a qualitative study using online focus groups. BMC Public Health (2013) 1.00
Assessing the introduction of universal human papillomavirus vaccination for preadolescent girls in The Netherlands. Vaccine (2007) 1.00
HPV16/18 vaccination to prevent cervical cancer in The Netherlands: model-based cost-effectiveness. Int J Cancer (2009) 0.99
Assessment of vaccine candidates for persons aged 50 and older: a review. BMC Geriatr (2013) 0.96
Underreporting of meningococcal disease incidence in the Netherlands: results from a capture-recapture analysis based on three registration sources with correction for false positive diagnoses. Eur J Epidemiol (2006) 0.93
Hospitalization due to varicella in the Netherlands. BMC Infect Dis (2011) 0.93
Two-component cluster analysis of a large serodiagnostic database for specificity of increases of IgG antibodies against pertussis toxin in paired serum samples and of absolute values in single serum samples. Clin Vaccine Immunol (2012) 0.92
Factors that influence vaccination decision-making by parents who visit an anthroposophical child welfare center: a focus group study. Adv Prev Med (2012) 0.91
Developing a vaccination evaluation model to support evidence-based decision making on national immunization programs. Vaccine (2006) 0.91
Comparatively low attendance during Human Papillomavirus catch-up vaccination among teenage girls in the Netherlands: Insights from a behavioral survey among parents. BMC Public Health (2012) 0.91
Valganciclovir for Congenital Cytomegalovirus. N Engl J Med (2015) 0.91
Acceptance of vaccination during pregnancy: experience with 2009 influenza A (H1N1) in the Netherlands. Vaccine (2012) 0.90
Estimation of household transmission rates of pertussis and the effect of cocooning vaccination strategies on infant pertussis. Epidemiology (2012) 0.90
Seroepidemiology of high-risk HPV in HIV-negative and HIV-infected MSM: the H2M study. Cancer Epidemiol Biomarkers Prev (2013) 0.90
Assessing the potential effects and cost-effectiveness of programmatic herpes zoster vaccination of elderly in the Netherlands. BMC Health Serv Res (2010) 0.89
Association between human papillomavirus vaccine uptake and cervical cancer screening in the Netherlands: implications for future impact on prevention. Int J Cancer (2012) 0.89
Clinical progression of high-grade cervical intraepithelial neoplasia: estimating the time to preclinical cervical cancer from doubly censored national registry data. Am J Epidemiol (2013) 0.88
Economic analysis of pertussis illness in the Dutch population: implications for current and future vaccination strategies. Vaccine (2009) 0.88
Mumps vaccine effectiveness in primary schools and households, the Netherlands, 2008. Vaccine (2012) 0.86
Invasive Pneumococcal Disease 3 Years after Introduction of 10-Valent Pneumococcal Conjugate Vaccine, the Netherlands. Emerg Infect Dis (2015) 0.85
Assessing the introduction of universal varicella vaccination in the Netherlands. Vaccine (2006) 0.85
Parental information-seeking behaviour in childhood vaccinations. BMC Public Health (2013) 0.85
An exploratory qualitative assessment of factors influencing childhood vaccine providers' intention to recommend immunization in the Netherlands. BMC Public Health (2012) 0.84
Participation in and attitude towards the national immunization program in the Netherlands: data from population-based questionnaires. BMC Public Health (2012) 0.84
[Antenatal screening in the Netherlands for HIV, hepatitis B and syphilis is effective]. Ned Tijdschr Geneeskd (2010) 0.84
Estimating the incidence of subclinical infections with Legionella Pneumonia using data augmentation: analysis of an outbreak in The Netherlands. Stat Med (2003) 0.84
Psychosocial determinants of parents' intention to vaccinate their newborn child against hepatitis B. Vaccine (2012) 0.83
Detection of systemic and mucosal HPV-specific IgG and IgA antibodies in adolescent girls one and two years after HPV vaccination. Hum Vaccin Immunother (2012) 0.82
Delayed start of diphtheria, tetanus, acellular pertussis and inactivated polio vaccination in preterm and low birth weight infants in the Netherlands. Pediatr Infect Dis J (2014) 0.81
Equity in human papilloma virus vaccination uptake?: sexual behaviour, knowledge and demographics in a cross-sectional study in (un)vaccinated girls in the Netherlands. BMC Public Health (2014) 0.81
Review: current knowledge on the role of HPV antibodies after natural infection and vaccination: implications for monitoring an HPV vaccination programme. J Med Virol (2013) 0.81
Changes in antibody seroprevalence of seven high-risk HPV types between nationwide surveillance studies from 1995-96 and 2006-07 in The Netherlands. PLoS One (2012) 0.80
Cost-effectiveness of targeted vaccination to protect new-borns against pertussis: comparing neonatal, maternal, and cocooning vaccination strategies. Vaccine (2013) 0.80
Population- and type-specific clustering of multiple HPV types across diverse risk populations in the Netherlands. Am J Epidemiol (2014) 0.79
Seroprevalence of Bordetella pertussis infection during pregnancy measured by IgG antibodies against pertussis toxin. Clin Infect Dis (2009) 0.78
Comparison of the tolerability of an acellular pertussis-containing vaccine given as the fifth booster dose in differently primed children. Vaccine (2011) 0.77
Economic Costs of Measles Outbreak in the Netherlands, 2013-2014. Emerg Infect Dis (2015) 0.77
Congenital Cytomegalovirus Infection: Child Development, Quality of Life and Impact on Daily Life. Pediatr Infect Dis J (2017) 0.75
[Pertussis in the Netherlands]. Ned Tijdschr Geneeskd (2010) 0.75
[Safety of the bivalent human papillomavirus vaccine--results following administration of more than 192,000 doses]. Ned Tijdschr Geneeskd (2009) 0.75
Pertussis in infancy and the association with respiratory and cognitive disorders at toddler age. Vaccine (2011) 0.75
Guillain-Barré syndrome: background incidence rates in The Netherlands. J Peripher Nerv Syst (2011) 0.75
Two doses of pandemic influenza A(H1N1) vaccine: tolerability in healthy young children in the Netherlands. Hum Vaccin (2011) 0.75
Effectiveness and impact of hepatitis B virus vaccination of children with at least one parent born in a hepatitis B virus endemic country: an early assessment. J Epidemiol Community Health (2009) 0.75
Parental reports of adverse events following simultaneously given dT-IPV and MMR vaccines in healthy 9-year-old children. Eur J Pediatr (2010) 0.75
Elevated Immune Response Among Children 4 Years Of Age With Pronounced Local Adverse Events After The Fifth Dtap Vaccination. Pediatr Infect Dis J (2017) 0.75
Estimating the population-level effectiveness of vaccination program in the Netherlands. Epidemiology (2017) 0.75